SAN FRANCISCO--(BUSINESS WIRE)--Aizon launches its Bioreactor Application, the pharma industry’s first predictive analysis and deep knowledge management application. The Aizon Bioreactor Application ...
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Gibcoâ„¢ CTSâ„¢ DynaXSâ„¢ Single Use Bioreactor, a purpose-built expansion platform designed to help cell therapy ...
Bioreactor makers should consider using additive manufacturing, also known as 3D printing, according to a study, which suggests the potential benefits of the approach would be worth the investment.
BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™) – a revolutionary platform ...
The MarketWatch News Department was not involved in the creation of this content. THE WOODLANDS, Texas, Dec. 2, 2025 /PRNewswire/ -- Cellipont Bioservices, a leading cell therapy Contract Development ...
Bioreactors have become irreplaceable tools in bioprocessing, revolutionizing the production of many biotechnological products. 1,2 They offer optimized and controlled environments to enhance cell ...
SOURCE WuXi PharmaTech (Cayman) Inc. SHANGHAI and TAIPEI, Oct. 30, 2013 - WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing ...
Laupheim, Germany, March 23, 2015 / B3C newswire / -- Rentschler Biotechnologie GmbH, a leading contract manufacturing and development organization (CDMO) for biopharmaceuticals, announced today that ...
An updated bioreactor based on rocking technology has more advanced controls but is easier for biopharmaceutical manufacturers to use. Single-use bioreactors come in all shapes and sizes that fit the ...
Global interest in cell and gene therapies is on the rise, and continued growth is expected for the coming years. To discuss the challenges and solutions associated with manufacturing viral vectors at ...
The application makes the power of AI accessible to pharma manufacturing while preserving GxP compliance, enabling data-driven decisions faster in the pursuit of bioreactor process optimization. SAN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results